Drug Type ASO |
Synonyms- |
Target |
Action blockers |
Mechanism Nav1.1 blockers(Sodium channel protein type I alpha subunit blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Epilepsies, Myoclonic | Preclinical | United States | 03 Dec 2021 |





